GlassScriptPhysician profile
Marsalis Brown
NPI 1558824672
$10,618.46
in general payments reported to CMS, 2019-2025
10 companies · $2,975 in 2025
The $2,975 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,976 · 2020: $1,273 · 2021: $1,200 · 2022: $1,347 · 2023: $273 · 2024: $1,575 · 2025: $2,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,700 · Food and Beverage: $1,723 · Education: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,700.21 |
| Food and Beverage | $1,722.96 |
| Education | $399.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $5,686.49 | 2019-2023 | |
| Smith+Nephew, INC. | $2,062.14 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Acufex Meniscal Root Repair, Q-Fix |
| Medical Device Business Services, INC. | $1,940.98 | 2024-2025 | Inhance, Rigidloop |
| Stryker Corporation | $433.57 | 2022-2024 | Mako, Variax, Accolade |
| Si-Bone, INC. | $151.91 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $144.20 | 2024 | Affixus |
| Depuy Synthes Sales INC. | $86.48 | 2024 | Dynacord, Truespan Orthocord, Expressew |
| Arthrex, INC. | $64.28 | 2024 | |
| Titan Surgical Group, LLC | $27.07 | 2025 | |
| Vericel Corporation | $21.34 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marsalis Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.